Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Open government data in health sector: a systematic literature review open government data in health sector.BMC public health · 2025
   Pooled it
2. Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis.BMJ (Clinical research ed.) · 2022
   Pooled it
3. The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern.Frontiers in public health · 2021
   Pooled it
4. Comparison of knowledge, perception and willingness to receive covid-19 vaccines among tertiary students in Osun State, Nigeria.African health sciences · 2023
   Article
5. COVID-19 vaccine hesitancy and attitudes in Pakistan: a cross-sectional phone survey of major urban cities.BMC public health · 2023
   Article
6. Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management.Vaccines · 2023
   Review
7. Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa.Southern African journal of infectious diseases · 2023
   Article
8. Assessment of COVID-19 vaccine acceptance and its associated factors in Debre Berhan City, Ethiopia, 2022.PloS one · 2023
   Article
9. Data standards and standardization: The shortest plank of bucket for the COVID-19 containment.The Lancet regional health. Western Pacific · 2022
   Review
10. An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.Computer methods and programs in biomedicine · 2022
    Article
11. Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
12. Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
13. A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study.Pathogens and global health · 2022
    Article
14. MALVIRUS: an integrated application for viral variant analysis.BMC bioinformatics · 2022
    Article
15. Identifying SARS-CoV-2 Variants of Concern through saliva-based RT-qPCR by targeting recurrent mutation sites.medRxiv : the preprint server for health sciences · 2022
    Article
16. The ins and outs of SARS-CoV-2 variants of concern (VOCs).Archives of virology · 2022
    Review
17. Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea.Frontiers in microbiology · 2022
    Article
18. Impact of second wave of COVID-19 pandemic on the hesitancy and refusal of COVID-19 vaccination in Puducherry, India: a longitudinal study.Human vaccines & immunotherapeutics · 2021
    Article
19. Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model.Vaccines · 2021
    Article
20. The Mediating Roles of Medical Mistrust, Knowledge, Confidence and Complacency of Vaccines in the Pathways from Conspiracy Beliefs to Vaccine Hesitancy.Vaccines · 2021
    Article

Corrections and comments

• Comment on
  Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.2021

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as